Resveratrol preserves the function of human platelets stored for transfusion

British Journal of Haematology

Volumn 172, Issue 5, 2016, Pages 794-806

  Lannan, Katie L ^a   Refaai, Majed A ^a   Ture, Sara K ^a   Morrell, Craig N ^a   Blumberg, Neil ^a   Phipps, Richard P ^a   Spinelli, Sherry L ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Apoptosis; Haemostasis; Platelet transfusion; Resveratrol; Thrombosis

Indexed keywords

CYCLOOXYGENASE 1; PROSTAGLANDIN E2; THROMBIN; THROMBOXANE B2; ANTITHROMBOCYTIC AGENT; AUTACOID; PROSTAGLANDIN SYNTHASE INHIBITOR; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLOOD CLOT; BLOOD VESSEL OCCLUSION; CELL PROTECTION; CONTROLLED STUDY; ENZYME INHIBITION; HEMOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PLASMA HALF LIFE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; ANIMAL; BLOOD STORAGE; C57BL MOUSE; DRUG EFFECTS; DRUG SCREENING; METABOLISM; PHYSIOLOGY; PROCEDURES; THROMBOCYTE;

ANIMALS; APOPTOSIS; BLOOD PLATELETS; BLOOD PRESERVATION; CYCLOOXYGENASE INHIBITORS; DRUG EVALUATION; HEMOSTASIS; HUMANS; INFLAMMATION MEDIATORS; MALE; MICE, INBRED C57BL; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET TRANSFUSION; STILBENES;

EID: 84958880376     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13862     Document Type: Article

References (57)

1. Bauer, J.H., Goupil, S., Garber, G.B. & Helfand, S.L. (2004) An accelerated assay for the identification of lifespan-extending interventions in Drosophila melanogaster. Proceedings of the National Academy of Sciences of the United States of America, 101, 12980-12985.
2. Baur, J.A. & Sinclair, D.A. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews. Drug Discovery, 5, 493-506.
3. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K., Pistell, P.J., Poosala, S., Becker, K.G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K.W., Spencer, R.G., Lakatta, E.G., Le Couteur, D., Shaw, R.J., Navas, P., Puigserver, P., Ingram, D.K., de Cabo, R. & Sinclair, D.A. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444, 337-342.
4. Bhat, K.P.L., Kosmeder, J.W. & Pezzuto, J.M. (2001) Biological effects of resveratrol. Antioxidants & Redox Signaling, 3, 1041-1064.
5. Blumberg, N., Gettings, K.F., Turner, C., Heal, J.M. & Phipps, R.P. (2006) An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion, 46, 1813-1821.
6. Boocock, D.J., Faust, G.E., Patel, K.R., Schinas, A.M., Brown, V.A., Ducharme, M.P., Booth, T.D., Crowell, J.A., Perloff, M., Gescher, A.J., Steward, W.P. & Brenner, D.E. (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiology, Biomarkers & Prevention, 16, 1246-1252.
7. Bowbrick, V.A., Mikhailidis, D.P. & Stansby, G. (2003) Influence of platelet count and activity on thromboelastography parameters. Platelets, 14, 219-224.
8. Cauwenberghs, S., van Pampus, E., Curvers, J., Akkerman, J.W. & Heemskerk, J.W. (2007) Hemostatic and signaling functions of transfused platelets. Transfusion Medicine Reviews, 21, 287-294.
9. Cognasse, F., Boussoulade, F., Chavarin, P., Acquart, S., Fabrigli, P., Lamy, B. & Garraud, O. (2006) Release of potential immunomodulatory factors during platelet storage. Transfusion, 46, 1184-1189.
10. Cook, D., Crowther, M., Meade, M., Rabbat, C., Griffith, L., Schiff, D., Geerts, W. & Guyatt, G. (2005) Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Critical Care Medicine, 33, 1565-1571.
11. Cookson, P., Thomas, S., Marschner, S., Goodrich, R. & Cardigan, R. (2012) In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days. Transfusion, 52, 983-994.
12. Curvers, J., van Pampus, E.C., Feijge, M.A., Rombout-Sestrienkova, E., Giesen, P.L. & Heemskerk, J.W. (2004) Decreased responsiveness and development of activation markers of PLTs stored in plasma. Transfusion, 44, 49-58.
13. Dash, S., Xiao, C., Morgantini, C., Szeto, L. & Lewis, G.F. (2013) High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 2895-2901.
14. Dobrydneva, Y., Williams, R.L. & Blackmore, P.F. (1999) trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets. British Journal of Pharmacology, 128, 149-157.
15. Fung, M.K., Grossman, B.J., Hillyer, C.D. & Westhoff, C.M. (2014) Technical Manual of the American Association of Blood Banks. American Association of Blood Banks (AABB), Bethesda, MD.
16. Gyulkhandanyan, A.V., Mutlu, A., Freedman, J. & Leytin, V. (2012) Markers of platelet apoptosis: methodology and applications. Journal of Thrombosis and Thrombolysis, 33, 397-411.
17. Hawiger, J. (1987) Formation and regulation of platelet and fibrin hemostatic plug. Human Pathology, 18, 111-122.
18. Heal, J.M., Phipps, R.P. & Blumberg, N. (2009) One big unhappy family: transfusion alloimmunization, thrombosis, and immune modulation/inflammation. Transfusion, 49, 1032-1036.
19. Howitz, K.T., Bitterman, K.J., Cohen, H.Y., Lamming, D.W., Lavu, S., Wood, J.G., Zipkin, R.E., Chung, P., Kisielewski, A., Zhang, L.L., Scherer, B. & Sinclair, D.A. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425, 191-196.
20. Iranshahy, M., Mohammadpoor, A.H., Hassanzadeh-Khayyat, M. & Iranshahi, M. (2013) Method validation for the one-month stability study of trans-resveratrol in human plasma. Jundishapur Journal of Natural Pharmaceutical Products, 8, 65-69.
21. Jackson, S.P. & Schoenwaelder, S.M. (2010) Procoagulant platelets: are they necrotic? Blood, 116, 2011-2018.
22. Juan, M.E., Vinardell, M.P. & Planas, J.M. (2002) The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. Journal of Nutrition, 132, 257-260.
23. Kaufman, J., Spinelli, S.L., Schultz, E., Blumberg, N. & Phipps, R.P. (2007) Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. Journal of Thrombosis and Haemostasis, 5, 788-796.
24. Khan, S.Y., Kelher, M.R., Heal, J.M., Blumberg, N., Boshkov, L.K., Phipps, R., Gettings, K.F., McLaughlin, N.J. & Silliman, C.C. (2006) Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood, 108, 2455-2462.
25. Khorana, A.A., Francis, C.W., Blumberg, N., Culakova, E., Refaai, M.A. & Lyman, G.H. (2008) Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Archives of Internal Medicine, 168, 2377-2381.
26. Kim, D.W., Kim, Y.M., Kang, S.D., Han, Y.M. & Pae, H.O. (2012) Effects of resveratrol and trans-3, 5, 4′-trimethoxystilbene on glutamate-induced cytotoxicity, heme oxygenase-1, and sirtuin 1 in HT22 neuronal cells. Biomolecules & Therapeutics, 20, 306-312.
27. Leytin, V. (2012) Apoptosis in the anucleate platelet. Blood Reviews, 26, 51-63.
28. Leytin, V. & Freedman, J. (2003) Platelet apoptosis in stored platelet concentrates and other models. Transfusion and Apheresis Science, 28, 285-295.
29. Muzzio, M., Huang, Z., Hu, S.C., Johnson, W.D., McCormick, D.L. & Kapetanovic, I.M. (2012) Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs. Journal of Pharmaceutical and Biomedical Analysis, 59, 201-208.
30. Ohto, H. & Nollet, K.E. (2011) Overview on platelet preservation: better controls over storage lesion. Transfusion and Apheresis Science, 44, 321-325.
31. Pace-Asciak, C.R., Hahn, S., Diamandis, E.P., Soleas, G. & Goldberg, D.M. (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clinica Chimica Acta, 235, 207-219.
32. Perales Villarroel, J.P., Figueredo, R., Guan, Y., Tomaiuolo, M., Karamercan, M.A., Welsh, J., Selak, M.A., Becker, L.B. & Sims, C. (2013) Increased platelet storage time is associated with mitochondrial dysfunction and impaired platelet function. Journal of Surgical Research, 184, 422-429.
33. Phipps, R.P., Kaufman, J. & Blumberg, N. (2001) Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet, 357, 2023-2024.
34. la Porte, C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N. & Cameron, D.W. (2010) Steady-state pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clinical Pharmacokinetics, 49, 449-454.
35. Poulsen, M.M., Vestergaard, P.F., Clasen, B.F., Radko, Y., Christensen, L.P., Stødkilde-Jørgensen, H., Møller, N., Jessen, N., Pedersen, S.B. & Jørgensen, J.O. (2013) High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes, 62, 1186-1195.
36. Reddoch, K.M., Pidcoke, H.F., Montgomery, R.K., Fedyk, C., Aden, J.K., Ramasubramanian, A.K. & Cap, A.P. (2013) Hemostatic function of apheresis platelets stored at 4°C and 22°C. Shock, 41, 54-61.
37. Refaai, M.A., Carter, J., Henrichs, K.F., Davidson, D.C., Pollock, S.J., Casey, A.E., Spinelli, S.L., Phipps, R.P., Francis, C.W. & Blumberg, N. (2013) Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and -B. Transfusion, 53, 382-393.
38. Rinder, H.M., Snyder, E.L., Tracey, J.B., Dincecco, D., Wang, C., Baril, L., Rinder, C.S. & Smith, B.R. (2003) Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: restoration of secretory function and maintenance of platelet survival. Transfusion, 43, 1230-1237.
39. Sahler, J., Grimshaw, K., Spinelli, S.L., Refaai, M.A., Phipps, R.P. & Blumberg, N. (2011) Platelet storage and transfusions: new concerns associated with an old therapy. Drug Discovery Today. Disease Mechanisms, 8, e9-e14.
40. Scherzberg, M.C., Kiehl, A., Zivkovic, A., Stark, H., Stein, J., Fürst, R., Steinhilber, D. & Ulrich-Rückert, S. (2015) Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action. Toxicology and Applied Pharmacology, 287, 67-76.
41. Shapira, S., Friedman, Z., Shapiro, H., Presseizen, K., Radnay, J. & Ellis, M.H. (2000) The effect of storage on the expression of platelet membrane phosphatidylserine and the subsequent impacton the coagulant function of stored platelets. Transfusion, 40, 1257-1263.
42. Skripchenko, A., Myrup, A., Thompson-Montgomery, D., Awatefe, H. & Wagner, S.J. (2011) Mitochondrial dysfunction of platelets stored in first- and second-generation containers is, in part, associated with elevated carbon dioxide levels. Transfusion, 51, 371-379.
43. Slichter, S.J. (2007) Platelet transfusion therapy. Hematology/oncology Clinics of North America, 21, 697-729, vii.
44. Slichter, S.J., Corson, J., Jones, M.K., Christoffel, T., Pellham, E., Bailey, S.L. & Bolgiano, D. (2014) Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS). Blood, 123, 271-280.
45. Sobotková, A., Másová-Chrastinová, L., Suttnar, J., Stikarová, J., Májek, P., Reicheltová, Z., Kotlín, R., Weisel, J.W., Malý, M. & Dyr, J.E. (2009) Antioxidants change platelet responses to various stimulating events. Free Radical Biology and Medicine, 47, 1707-1714.
46. Spiess, B.D. (2004) Risks of transfusion: outcome focus. Transfusion, 44, 4S-14S.
47. Spiess, B.D., Royston, D., Levy, J.H., Fitch, J., Dietrich, W., Body, S., Murkin, J. & Nadel, A. (2004) Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion, 44, 1143-1148.
48. Springer, D.L., Miller, J.H., Spinelli, S.L., Pasa-Tolic, L., Purvine, S.O., Daly, D.S., Zangar, R.C., Jin, S., Blumberg, N., Francis, C.W., Taubman, M.B., Casey, A.E., Wittlin, S.D. & Phipps, R.P. (2009) Platelet proteome changes associated with diabetes and during platelet storage for transfusion. Journal of Proteome Research, 8, 2261-2272.
49. Strong, R., Miller, R.A., Astle, C.M., Baur, J.A., de Cabo, R., Fernandez, E., Guo, W., Javors, M., Kirkland, J.L., Nelson, J.F., Sinclair, D.A., Teter, B., Williams, D., Zaveri, N., Nadon, N.L. & Harrison, D.E. (2013) Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 68, 6-16.
50. Szewczuk, L.M., Forti, L., Stivala, L.A. & Penning, T.M. (2004) Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. Journal of Biological Chemistry, 279, 22727-22737.
51. Tormey, C.A. & Stack, G. (2009) Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies. Blood, 114, 4279-4282.
52. Viswanathan, M., Kim, S.K., Berdichevsky, A. & Guarente, L. (2005) A role for SIR-2.1 regulation of ER stress response genes in determining C. elegans life span. Developmental Cell, 9, 605-615.
53. Walle, T., Hsieh, F., DeLegge, M.H., Oatis, J.E. & Walle, U.K. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition, 32, 1377-1382.
54. Wang, C., Wheeler, C.T., Alberico, T., Sun, X., Seeberger, J., Laslo, M., Spangler, E., Kern, B., de Cabo, R. & Zou, S. (2013) The effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melanogaster. Age (Dordrecht, Netherlands), 35, 69-81.
55. Weyrich, A.S. & Zimmerman, G.A. (2004) Platelets: signaling cells in the immune continuum. Trends in Immunology, 25, 489-495.
56. Wiinberg, B., Jensen, A.L., Rojkjaer, R., Johansson, P., Kjelgaard-Hansen, M. & Kristensen, A.T. (2005) Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Veterinary Clinical Pathology, 34, 389-393.
57. Wood, J.G., Rogina, B., Lavu, S., Howitz, K., Helfand, S.L., Tatar, M. & Sinclair, D. (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 430, 686-689.